India Launches Anti-Dumping Investigation into Ethyl Chloroformate Imports from China

India has initiated an anti-dumping investigation into ethyl chloroformate imports from China, responding to allegations from domestic producer Paushak. The company claims that these imports are being sold at unfairly low prices, which is detrimental to local industry. The Directorate General of Trade Remedies (DGTR) has begun the probe to determine if anti-dumping duties are necessary to protect domestic producers from material injury caused by these imports.

DGTR Launches Investigation Following Paushak’s Complaint

The Directorate General of Trade Remedies (DGTR), operating under the Union commerce ministry, has commenced an investigation into the alleged dumping of ethyl chloroformate from China. This action follows a formal complaint from Paushak, which asserts that it is the sole domestic producer of this chemical in India. The company claims that the influx of low-priced imports from China has resulted in “material injury” to its operations. The DGTR will evaluate whether these imports are indeed being sold at prices that undermine local production and whether imposing anti-dumping duties is warranted to safeguard the domestic industry.

Importance of Ethyl Chloroformate in Key Industries

Ethyl chloroformate is a crucial organic chemical intermediate widely utilized in the pharmaceutical and agrochemical sectors. Its significance in these industries means that any potential anti-dumping duties could have far-reaching consequences. If the investigation confirms dumping and duties are imposed, it could lead to increased input costs for pharmaceutical manufacturers and agrochemical companies. This situation poses a dilemma, as it aims to protect local producers while potentially raising costs for downstream industries that rely on this chemical. Paushak has indicated that the surge in imports from China has suppressed prices in the domestic market, adversely affecting its profitability.

Preliminary Findings Indicate Price Undercutting

The DGTR’s preliminary assessment suggests that the dumping margin for ethyl chloroformate imports from China exceeds the de minimis threshold, indicating significant price undercutting. This finding is a critical factor in anti-dumping investigations. The inquiry will span from October 2024 to September 2025, during which the DGTR will gather submissions and evidence from various stakeholders, including exporters and importers. The outcome of this investigation will determine whether the DGTR will recommend the imposition of duties to the central government.

Broader Context of Trade Scrutiny on Imports

This investigation is part of India’s broader strategy to address the challenges posed by low-cost imports, particularly from China. In December, the Indian government implemented a three-year import tariff on certain steel products to mitigate the impact of cheap imports. Additionally, the DGTR has launched a separate anti-dumping investigation into hexamine imports from China, Russia, and the United Arab Emirates. These concurrent investigations highlight a growing regulatory focus on chemical imports that domestic producers claim are undermining Indian manufacturing, which could have significant implications for industrial policy and input costs across critical sectors like pharmaceuticals and agrochemicals.


Observer Voice is the one stop site for National, International news, Sports, Editor’s Choice, Art/culture contents, Quotes and much more. We also cover historical contents. Historical contents includes World History, Indian History, and what happened today. The website also covers Entertainment across the India and World.

Follow Us on Twitter, Instagram, Facebook, & LinkedIn

OV News Desk

The OV News Desk comprises a professional team of news writers and editors working round the clock to deliver timely updates on business, technology, policy, world affairs, sports and current events. The desk combines editorial judgment with journalistic integrity to ensure every story is accurate, fact-checked, and relevant. From market… More »
Back to top button